News
Chinese biotech HuidaGene reports early success with first CRISPR brain treatment in 9-year-old with MECP2 duplication ...
Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback